Supporting Families. Saving Lives.
Sign-up for our Enewsletter here.
You have an opportunity to help advance research for Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) also known as Arrhythmogenic Right Ventricular Dysplasia (ARVD). Cydan is collaborating with Sanguine, a provider of at-home clinical research services, to give you the opportunity to contribute to the development of new ARVC/D treatments from home.
Participation requires a simple blood donation, and a mobile medical professional will work around your schedule to meet you in the comfort of your home and perform the blood draw. The blood samples will be sent to researchers at Cydan for testing and analysis, and the samples will be used for this research study only.
With the growing concern regarding the spread of COVID-19, all mobile medical professionals will be provided personal protective equipment (PPE) including gowns, face masks, gloves, hand sanitizer, and alcohol wipes in order to protect our participants and staff against the spread of the virus.
You will receive $50 compensation as a thank you for your time.
You may qualify to participate if you:
To learn more or sign up, Contact us at sads@sads.org.
----------------------------
What is preclinical research?
In preclinical research, researchers test their theories on human samples like blood rather than human participants. This phase helps researchers determine the safest and most effective way to move forward with their project and often helps define the parameters of future clinical trials.
How will my blood donation help?
Researchers will always rely on samples from the patient population that they are researching in order to perform their preclinical research. Your blood is special. It is the key to new therapies and diagnostics. Without it, researchers cannot move forward with their clinical tests and research projects are stalled or put on hold.